In this large, long term follow-up cohort study of OPSCC and its subsites, we disclosed that p16+ was correlated to a favorable OS and DFS in patients with TSCC/BOTSCC as compared to those with corresponding p16− cancer, while in patients with otherOPSCC, no such analogy was observed. Here, CDKN2A is linked to cancer.